Home › Funds › Solas Capital Management, LLC › MAIA
Solas Capital Management, LLC position in MAIA
MAIA BIOTECHNOLOGY INC · Health Care
Solas Capital Management, LLC reported holding 3,030,845 shares of MAIA (MAIA BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$4.4M, representing 2.34% of its reported portfolio and ranking #16 among its reported holdings. Solas Capital Management, LLC has disclosed MAIA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Solas Capital Management, LLC's MAIA position evolved
Solas Capital Management, LLC first disclosed a stake in MAIA in Q1 2026 at 4,297,004 shares (US$6.0M). Across 2 filings, Solas Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,030,845 shares valued at US$4.4M — a reduction of -1,266,159 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 4.30M | $6.02M | New |
| Q2 2026 | 3.03M | $4.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MAIA and 13F data
MAIA (MAIA BIOTECHNOLOGY INC) is a Health Care company. 37 other funds we track also report a position in MAIA — the largest reported positions include Bleichroeder LP (US$720K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Solas Capital Management, LLC
FAQ
How long has Solas Capital Management, LLC held MAIA?
Solas Capital Management, LLC has disclosed MAIA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Solas Capital Management, LLC's current position in MAIA?
As of Q2 2026, Solas Capital Management, LLC holds 3.03M shares of MAIA (MAIA BIOTECHNOLOGY INC), valued at $4.36M, representing 2.34% of its reported portfolio and ranking #16.
Has Solas Capital Management, LLC been buying or selling MAIA?
In the latest 13F filing (Q2 2026), Solas Capital Management, LLC reduced its position in MAIA.
Which other funds hold MAIA?
Other major institutional holders of MAIA include Bleichroeder LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.